News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
485,578 Results
Type
Article (8017)
Company Profile (140)
Press Release (477420)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166739)
Career Advice (304)
Deals (25738)
Drug Delivery (7)
Drug Development (52873)
Employer Resources (14)
FDA (9762)
Job Trends (8572)
News (238194)
Policy (17898)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (489)
Accelerated approval (25)
ADA (18)
Adcomms (1)
Allergies (97)
Alliances (33161)
ALS (106)
Alzheimer's disease (984)
Antibody-drug conjugate (ADC) (275)
Approvals (10399)
Artificial intelligence (323)
ASCO (159)
Autoimmune disease (215)
Automation (28)
Bankruptcy (263)
Best Places to Work (6963)
BIO (36)
Biologics (6)
BIOSECURE Act (1)
Biosimilars (114)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (139)
Brain cancer (30)
Breast cancer (516)
Cancer (3706)
Cardiovascular disease (224)
Career advice (246)
Career pathing (1)
CAR-T (177)
CDMO (10)
Celiac Disease (1)
Cell therapy (483)
Cervical cancer (35)
Clinical research (47978)
Collaboration (1267)
Commercialization (3)
Compensation (1514)
Complete response letters (34)
COVID-19 (760)
CRISPR (64)
C-suite (785)
Cystic fibrosis (86)
Data (5787)
Denatured (4)
Depression (103)
Dermatology (66)
Diabetes (350)
Diagnostics (4200)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (158)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (166)
Earnings (73739)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (88007)
Executive appointments (710)
FDA (12449)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (933)
Gene editing (126)
Generative AI (9)
Gene therapy (329)
GLP-1 (294)
Government (955)
Grass and pollen (2)
Guidances (281)
Healthcare (9377)
Hematology (94)
HIV (53)
Huntington's disease (22)
IgA nephropathy (65)
Immunology and inflammation (100)
Immuno-oncology (60)
Indications (159)
Infectious disease (950)
Inflammatory bowel disease (127)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (259)
Interviews (42)
IPO (12388)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5209)
Licensing (16)
Liver cancer (45)
Longevity (19)
Lung cancer (518)
Lymphoma (256)
Machine learning (27)
Management (3)
Manufacturing (548)
Marketing (8)
MASH (118)
Medical affairs (2)
Medical device (8670)
Medtech (8823)
Mergers & acquisitions (14399)
Metabolic disorders (718)
mRNA (60)
Multiple sclerosis (105)
NASH (4)
Neurodegenerative disease (223)
Neuropsychiatric disorders (40)
Neuroscience (1849)
NextGen: Class of 2026 (3153)
Non-profit (847)
Obesity (227)
Opinion (10)
Ovarian cancer (160)
Pain (176)
Pancreatic cancer (204)
Parkinson's disease (204)
Partnered (12)
Patents (489)
Patient recruitment (520)
Peanut (31)
People (41324)
Pharmaceutical (30)
Pharmacy benefit managers (9)
Phase 1 (15499)
Phase 2 (21419)
Phase 3 (14446)
Pipeline (7578)
Policy (18)
Postmarket research (1572)
Preclinical (6548)
Press Release (34)
Prostate cancer (193)
Psychedelics (7)
Radiopharmaceuticals (193)
Rare diseases (583)
Real estate (3024)
Recruiting (6)
Regulatory (14908)
Reports (22)
Research institute (584)
Resumes & cover letters (46)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (102)
Series A (158)
Series B (122)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (89)
Sponsored (5)
Startups (2019)
Stomach cancer (3)
Supply chain (50)
Vaccines (332)
Venture capital (17)
Weight loss (74)
Women's health (83)
Date
Today (113)
Last 7 days (392)
Last 30 days (1500)
Last 365 days (19028)
2026 (13204)
2025 (19251)
2024 (22986)
2023 (26542)
2022 (34587)
2021 (37167)
2020 (33479)
2019 (23275)
2018 (17468)
2017 (18768)
2016 (17918)
2015 (24272)
2014 (21681)
2013 (18139)
2012 (20221)
2011 (20441)
2010 (20332)
Location
Africa (228)
Alabama (75)
Alaska (2)
Arizona (308)
Arkansas (11)
Asia (17935)
Australia (2106)
California (12245)
Canada (3204)
China (537)
Colorado (490)
Connecticut (423)
Delaware (210)
Europe (24669)
Florida (1834)
Georgia (389)
Hawaii (3)
Idaho (46)
Illinois (714)
India (52)
Indiana (320)
Iowa (16)
Japan (415)
Kansas (101)
Kentucky (31)
Louisiana (27)
Maine (26)
Maryland (1218)
Massachusetts (8032)
Michigan (310)
Minnesota (567)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (119)
New Hampshire (60)
New Jersey (2665)
New Mexico (12)
New York (2869)
North Carolina (1303)
North Dakota (4)
Northern California (6154)
Ohio (287)
Oklahoma (14)
Oregon (16)
Pennsylvania (2283)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (77)
South Dakota (1)
Southern California (5092)
Tennessee (122)
Texas (1984)
United States (39659)
Utah (366)
Vermont (1)
Virginia (155)
Washington D.C. (38)
Washington State (951)
West Virginia (1)
Wisconsin (74)
Wyoming (1)
485,578 Results for "renovorx inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
RenovoRx Regains Compliance with Nasdaq Minimum Bid Price Requirement
August 23, 2026
·
9 min read
Press Releases
RenovoRx to Present at H.C. Wainwright 28th Annual Global Investment Conference, September 14th-16th
September 2, 2026
·
10 min read
Press Releases
RenovoRx Reports Record Second Quarter 2026 Results, Driven by Accelerating Commercial Adoption and 61% Sequential Quarterly Revenue Growth
August 13, 2026
·
23 min read
Press Releases
RenovoRx Achieves Major Milestone with Full Enrollment in Phase III TIGeR-PaC Trial for Locally Advanced Pancreatic Cancer
August 11, 2026
·
12 min read
Press Releases
RenovoRx Highlights Peer-Reviewed Publication of Pharmacokinetic and Pharmacodynamic (PK/PD) Data Supporting TAMP™ Platform’s Targeted Drug-Delivery in Locally Advanced Pancreatic Cancer
August 25, 2026
·
11 min read
Press Releases
RenovoRx to Highlight TAMP™ Platform at JonesTrading Virtual Key Opinion Leader Webinar on the Evolving Pancreatic Cancer Landscape, August 13th
August 4, 2026
·
9 min read
Press Releases
RenovoRx Announces First Commercial Clinical Use of RenovoCath® in Sarcoma Patient Treatment, Marking Expansion of Targeted Drug-Delivery Device to Other Solid Tumors
August 6, 2026
·
9 min read
Press Releases
RenovoRx Receives Notice of Allowance for New U.S. Patent Covering RenovoCath®, an Advanced Dual-Occlusion Catheter, for Targeted Therapeutic Drug-Delivery for Cancer Treatment
August 20, 2026
·
10 min read
Press Releases
Clinical Data Supporting Targeted Chemotherapeutic Delivery via RenovoRx’s TAMP™ Therapy Platform Presented at 2026 SIR Annual Scientific Meeting
April 14, 2026
·
10 min read
Press Releases
RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET
July 29, 2026
·
8 min read
1 of 48,558
Next
